Usana Health Sciences Inc – ‘8-K’ for 5/22/06

On:  Wednesday, 5/24/06, at 3:58pm ET   ·   For:  5/22/06   ·   Accession #:  1157523-6-5565   ·   File #:  0-21116

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Usana 8K                                               3     12K 
 2: EX-10.1     Material Contract                                     14     59K 
 3: EX-10.2     Material Contract                                     14     59K 

8-K   —   Usana 8K
Document Table of Contents

8-K
1st Page of 3
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
3                                                                               

 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549
------------
FORM 8-K
------------
CURRENT REPORT

Pursuant to Section 13 or 15(d) of

 the Securities Exchange Act of 1934

 Date of Report (Date of Earliest Event Reported):
May 22, 2006
 USANA HEALTH SCIENCES, INC.

(Exact name of registrant as specified in its charter)

 Commission File No. 0-21116

Utah                                    87-0500306  
(State or other jurisdiction of             (IRS Employer Identification      
incorporation)                                 Number)        

 3838 West Parkway Boulevard
Salt Lake City, Utah 84120
(Address of principal executive offices, Zip Code)

Registrant's telephone number, including area code: (801) 954-7100

 Former name or former address, if changed since last report: Not Applicable

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:                                                           

[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
CFR 230.425)                                                          

[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)                                                           

[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
Exchange Act (17 CFR 240.14d-2(b))                                    

[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
Exchange Act (17 CFR 240.13e-4(c))                                    

8-K
2nd Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 2nd
Item 1.01         Entry into a Material Definitive Agreement.                   

On May 22, 2006,  USANA  Health  Sciences,  Inc.  (the  "Company")  entered into
indemnification  agreements (the "Indemnification  Agreements") with each of its
directors,  Robert  Anciaux,  Jerry G.  McClain,  Ronald  S.  Poelman,  Denis E.
Waitley,  Ph.D.  and Myron W. Wentz,  Ph.D.,  and with the  following  executive
officers:  Fred W. Cooper,  Gilbert A. Fuller,  Kevin  Guest,  G. Doug  Hekking,
Bradford  Richardson,  David A. Wentz,  Mark H. Wilson,  and Timothy  Wood.  The
Indemnification  Agreements,  among other things, provide for indemnification of
the  respective  director or officer for judgments,  settlements,  penalties and
fines  incurred by such person in any action or  proceeding  arising out of such
person's  services as a director  or officer of the Company or at the  Company's
request. The Indemnification Agreements also provide for advancement of expenses
to the indemnified person in connection with a legal proceeding.                

In  addition  to the  Indemnification  Agreements,  the  Company's  Amended  and
Restated  Articles of Incorporation and Bylaws provide for  indemnification  and
advancement  of expenses for directors and officers.  The Company  believes that
these  provisions and  agreements are necessary to attract and retain  qualified
persons to serve as directors  and officers.  There is no pending  litigation or
proceeding  relating to the Company involving any of the Company's  directors or
officers.                                                                       

The foregoing description of the Indemnification  Agreements does not purport to
be complete and is qualified in its entirety by reference to the Indemnification
Agreements.  Forms of  Indemnification  Agreements  for  directors  and  certain
officers of the Company are filed as Exhibit 10.1 and Exhibit  10.2 hereto,  and
are incorporated herein by reference.                                           

Item 9.01 Financial Statements and Exhibits. (furnished herewith)               

(d) Exhibits                                                                    

Exhibit No. Description                                             

         10.1     Form of Indemnification  Agreement between the Company and its
directors.                                  

         10.2     Form of  Indemnification  Agreement  between  the  Company and
certain of its officers.                    

8-K
Last Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 3rd
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the        
registrant has duly caused this report to be signed on its behalf by the        
undersigned hereunto duly authorized.                                           

                       USANA HEALTH SCIENCES, INC.

                     By: /s/ Gilbert A. Fuller
                       ---------------------------
              Gilbert A. Fuller,
                   Chief Financial Officer

Date: May 24, 2006                                                              

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on:		5/24/06		3					None on these Dates
For Period End:		5/22/06		1		2
									List all Filings

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/24  Usana Health Sciences Inc.        10-K       12/30/23   95:9.5M
 2/28/23  Usana Health Sciences Inc.        10-K       12/31/22   93:10M
 3/01/22  Usana Health Sciences Inc.        10-K        1/01/22   90:10M                                    RDG Filings/FA
 3/02/21  Usana Health Sciences Inc.        10-K        1/02/21   91:10M                                    RDG Filings/FA